Novartis | NOVN - Trade Debtors

Stock Price
122.18
Daily Change
1.00 0.83%
Monthly
0.15%
Yearly
44.23%
Q2 Forecast
120.10

Novartis reported $12.29B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alcon AG USD 2.54B 596M Dec/2025
Almirall EUR 175.93M 17.87M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Autolus Therapeutics Ltd USD 91.36M 58.83M Sep/2025
Bayer EUR 14.19B 720M Dec/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Fresenius EUR 4.08B 18M Sep/2025
Fresenius Medical Care EUR 3.66B 382.33M Dec/2025
Galapagos EUR 199.75M 122.08M Dec/2025
Genmab DKK 1.17B 119M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
GRIFOLS EUR 852M 244.52M Dec/2025
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
J&J USD 17.61B 235M Sep/2025
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.44B 293M Dec/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 12.29B 3.3B Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Orion EUR 429.2M 46.9M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Philips EUR 3.8B 266M Dec/2025
Recordati EUR 699.76M 472K Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 397M 100M Dec/2025
UCB EUR 1.97B 54M Dec/2025